3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate

C95H121N27O5 — CID 158684821

IUPAC3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate
SMILESCOC(=O)c1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1.O=C1CCCN1c1n[nH]c2ccnc(NC3CCCCC3)c12.OCCCc1[nH]nc2ccnc(NC3CCCCC3)c12.c1cc2[nH]nc(-c3cnn(CCN4CCOCC4)c3)c2c(NC2CCCCC2)n1.c1ccc(Cn2cc(-c3n[nH]c4ccnc(NC5CCCCC5)c34)cn2)nc1
InChIInChI=1S/C22H26N4O2.C21H29N7O.C21H23N7.C16H21N5O.C15H22N4O/c1-28-22(27)16-10-7-15(8-11-16)9-12-18-20-19(26-25-18)13-14-23-21(20)24-17-5-3-2-4-6-17;1-2-4-17(5-3-1)24-21-19-18(6-7-22-21)25-26-20(19)16-14-23-28(15-16)9-8-27-10-12-29-13-11-27;1-2-6-16(7-3-1)25-21-19-18(9-11-23-21)26-27-20(19)15-12-24-28(13-15)14-17-8-4-5-10-22-17;22-13-7-4-10-21(13)16-14-12(19-20-16)8-9-17-15(14)18-11-5-2-1-3-6-11;20-10-4-7-12-14-13(19-18-12)8-9-16-15(14)17-11-5-2-1-3-6-11/h7-8,10-11,13-14,17H,2-6,9,12H2,1H3,(H,23,24)(H,25,26);6-7,14-15,17H,1-5,8-13H2,(H,22,24)(H,25,26);4-5,8-13,16H,1-3,6-7,14H2,(H,23,25)(H,26,27);8-9,11H,1-7,10H2,(H,17,18)(H,19,20);8-9,11,20H,1-7,10H2,(H,16,17)(H,18,19)
InChIKeyIFPHHVNRUYGEOY-UHFFFAOYSA-N
MW1721.20 g/mol
LogP16.64
Rot. Bonds25

About 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate

3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate (PubChem CID 158684821) has the molecular formula C95H121N27O5 and a molecular weight of 1721.20 g/mol. Its IUPAC name is 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate.

Molecular Properties

Compound Name3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate
PubChem CID158684821
Molecular FormulaC95H121N27O5
Molecular Weight1721.20 g/mol
Exact Mass1720.00
IUPAC Name3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate
SMILESCOC(=O)c1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1.O=C1CCCN1c1n[nH]c2ccnc(NC3CCCCC3)c12.OCCCc1[nH]nc2ccnc(NC3CCCCC3)c12.c1cc2[nH]nc(-c3cnn(CCN4CCOCC4)c3)c2c(NC2CCCCC2)n1.c1ccc(Cn2cc(-c3n[nH]c4ccnc(NC5CCCCC5)c34)cn2)nc1
InChIInChI=1S/C22H26N4O2.C21H29N7O.C21H23N7.C16H21N5O.C15H22N4O/c1-28-22(27)16-10-7-15(8-11-16)9-12-18-20-19(26-25-18)13-14-23-21(20)24-17-5-3-2-4-6-17;1-2-4-17(5-3-1)24-21-19-18(6-7-22-21)25-26-20(19)16-14-23-28(15-16)9-8-27-10-12-29-13-11-27;1-2-6-16(7-3-1)25-21-19-18(9-11-23-21)26-27-20(19)15-12-24-28(13-15)14-17-8-4-5-10-22-17;22-13-7-4-10-21(13)16-14-12(19-20-16)8-9-17-15(14)18-11-5-2-1-3-6-11;20-10-4-7-12-14-13(19-18-12)8-9-16-15(14)17-11-5-2-1-3-6-11/h7-8,10-11,13-14,17H,2-6,9,12H2,1H3,(H,23,24)(H,25,26);6-7,14-15,17H,1-5,8-13H2,(H,22,24)(H,25,26);4-5,8-13,16H,1-3,6-7,14H2,(H,23,25)(H,26,27);8-9,11H,1-7,10H2,(H,17,18)(H,19,20);8-9,11,20H,1-7,10H2,(H,16,17)(H,18,19)
InChIKeyIFPHHVNRUYGEOY-UHFFFAOYSA-N
XLogP16.64
TPSA395.84 Ų
H-Bond Donors11
H-Bond Acceptors26
Rotatable Bonds25
Heavy Atoms127
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001721.20
LogP ≤ 516.64
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1026

Analyze 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(2-phenylmorpholin-4-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(4-phenylpiperidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-(3-phenylpyrrolidin-1-yl)propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[3-(trifluoromethyl)piperidin-1-yl]propan-1-one;3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]-1-[4-(trifluoromethyl)piperidin-1-yl]propan-1-one
CID 161107372
N-[6-(azepan-1-yl)-1-[(4-methylphenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]benzamide;N-[6-(azepan-1-yl)-1-[(4-methylphenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]cyclohexanecarboxamide;6-(azepan-1-yl)-1-[(4-methylphenyl)methyl]-3-(pyridin-4-ylmethoxymethyl)pyrazolo[3,4-b]pyridine;ethyl (2R)-1-[3-(2-piperidin-4-ylacetyl)-2H-pyrazolo[3,4-b]pyridin-6-yl]pyrrolidine-2-carboxylate;pentakis(2,2,2-trifluoroacetic acid);1,1,1-trifluoropropan-2-one
CID 161291608
3-(aminomethyl)-4-methoxy-6-methyl-1H-pyridin-2-one;ethyl 6-methyl-5-[methyl(piperidin-4-yl)amino]-1-(1H-pyrazol-5-yl)indolizine-7-carboxylate;ethyl 6-methyl-5-[methyl-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]amino]-1-(1H-pyrazol-5-yl)indolizine-7-carboxylate;ethyl trifluoromethanesulfonate;N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-[methyl-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]amino]-1-(1H-pyrazol-5-yl)indolizine-7-carboxamide;6-methyl-5-[methyl-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]amino]-1-(1H-pyrazol-5-yl)indolizine-7-carboxylic acid;hydrochloride
CID 161707373
[(2S,3R)-2-[[(5-ethylpyrimidin-2-yl)amino]methyl]-3-methylpiperidin-1-yl]-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)methanone;[(2S)-2-[2-(5-ethylpyrimidin-2-yl)ethyl]pyrrolidin-1-yl]-(2-phenyl-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-3-yl)methanone;(2-phenyl-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-3-yl)-[(2S)-2-[(3-phenylpyrazol-1-yl)methyl]pyrrolidin-1-yl]methanone;(2-phenyl-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-3-yl)-[(2S)-2-[2-[5-(trifluoromethyl)-2-pyridinyl]ethyl]pyrrolidin-1-yl]methanone
CID 167685028
[(1S)-2-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]piperazin-1-yl]-2-oxo-1-phenylethyl] acetate;(2R)-1-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]piperazin-1-yl]-2-phenylbutan-1-one
CID 87283359
[2-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]piperazin-1-yl]-2-oxo-1-phenylethyl] acetate;(2R)-1-[4-[4-[(5-methyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]piperazin-1-yl]-2-phenylbutan-1-one
CID 87283360
[3-[6-[[(1S)-1-phenylethyl]amino]-2-pyridinyl]pyrazolo[1,5-a]pyridin-5-yl]methanol;3-[6-(piperidin-4-ylamino)-2-pyridinyl]pyrazolo[1,5-a]pyridine-5-carboxylic acid;N-piperidin-4-yl-6-pyrazolo[1,5-a]pyridin-3-ylpyridin-2-amine
CID 89734814
[3-[6-[[(1S)-1-phenylethyl]amino]-2-pyridinyl]pyrazolo[1,5-a]pyridin-5-yl]methyl 3-[6-(piperidin-4-ylamino)-2-pyridinyl]pyrazolo[1,5-a]pyridine-5-carboxylate;N-piperidin-4-yl-6-pyrazolo[1,5-a]pyridin-3-ylpyridin-2-amine
CID 89734816
[3-[6-(1-phenylethylamino)-2-pyridinyl]pyrazolo[1,5-a]pyridin-5-yl]methanol;3-[6-(piperidin-4-ylamino)-2-pyridinyl]pyrazolo[1,5-a]pyridine-5-carboxylic acid;N-piperidin-4-yl-6-pyrazolo[1,5-a]pyridin-3-ylpyridin-2-amine
CID 89734818
N-[[2-[4-(cyclopropylcarbamoyl)anilino]-8-(2-methylpyrazol-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-3-ium-3-yl]methyl]-4-[5-[4-[[4-[2-[4-(cyclopropylcarbamoyl)anilino]-[1,2,4]triazolo[1,5-a]pyridin-8-yl]phenyl]methyl]morpholin-2-yl]-2-(1H-pyrazol-4-ylamino)-[1,2,4]triazolo[1,5-a]pyridin-8-yl]-N-methylbenzamide
CID 90925071
N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate
CID 157089424
3-[4-[(5-acetyl-1-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-3-yl)amino]phenyl]-N-methylbenzamide;1-[3-[4-(3-cyclopropyl-1-methylpyrazol-4-yl)anilino]-1-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone;1-[3-[4-(1-cyclopropylpyrazol-4-yl)anilino]-1-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone;1-[3-[4-[3-(hydroxymethyl)phenyl]anilino]-1-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone;1-[1-methyl-3-[(4-pyridin-4-ylphenyl)methyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone;1-[1-methyl-3-[4-(4,5,6,7-tetrahydropyrazolo[1,5-a]pyridin-3-yl)anilino]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]ethanone
CID 157150185

Frequently Asked Questions

What is the IUPAC name of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate?
The IUPAC name of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate (CID 158684821) is 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate.
What is the SMILES notation for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate?
The canonical SMILES for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate is COC(=O)c1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1.O=C1CCCN1c1n[nH]c2ccnc(NC3CCCCC3)c12.OCCCc1[nH]nc2ccnc(NC3CCCCC3)c12.c1cc2[nH]nc(-c3cnn(CCN4CCOCC4)c3)c2c(NC2CCCCC2)n1.c1ccc(Cn2cc(-c3n[nH]c4ccnc(NC5CCCCC5)c34)cn2)nc1.
What is the InChIKey of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate?
The InChIKey is IFPHHVNRUYGEOY-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26N4O2.C21H29N7O.C21H23N7.C16H21N5O.C15H22N4O/c1-28-22(27)16-10-7-15(8-11-16)9-12-18-20-19(26-25-18)13-14-23-21(20)24-17-5-3-2-4-6-17;1-2-4-17(5-3-1)24-21-19-18(6-7-22-21)25-26-20(19)16-14-23-28(15-16)9-8-27-10-12-29-13-11-27;1-2-6-16(7-3-1)25-21-19-18(9-11-23-21)26-27-20(19)15-12-24-28(13-15)14-17-8-4-5-10-22-17;22-13-7-4-10-21(13)16-14-12(19-20-16)8-9-17-15(14)18-11-5-2-1-3-6-11;20-10-4-7-12-14-13(19-18-12)8-9-16-15(14)17-11-5-2-1-3-6-11/h7-8,10-11,13-14,17H,2-6,9,12H2,1H3,(H,23,24)(H,25,26);6-7,14-15,17H,1-5,8-13H2,(H,22,24)(H,25,26);4-5,8-13,16H,1-3,6-7,14H2,(H,23,25)(H,26,27);8-9,11H,1-7,10H2,(H,17,18)(H,19,20);8-9,11,20H,1-7,10H2,(H,16,17)(H,18,19).
What are the key properties of 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate?
3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate has a molecular weight of 1721.20 g/mol, XLogP of 16.64, 25 rotatable bonds, 11 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate is sourced from PubChem (CID 158684821), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).